Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: capecitabine|DRUG: irinotecan hydrochloride
Sponsor: Montefiore Medical Center
Collaborators: National Cancer Institute (NCI)